SOUTH FLORIDA'S ACCESS TO AFFORDABLE PRESCRIPTION DRUGS: COSTS..., HEARING... SERIAL NO. 108-9... COMMITTEE ON ENERGY & COMMERCE, HOUSE OF R.
Author:
Publisher:
Published: 2003*
Total Pages:
ISBN-13:
DOWNLOAD EBOOKRead and Download eBook Full
Author:
Publisher:
Published: 2003*
Total Pages:
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
Published: 2003
Total Pages: 94
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
Published: 2003
Total Pages: 96
ISBN-13:
DOWNLOAD EBOOKAuthor:
Publisher:
Published: 2003
Total Pages: 100
ISBN-13:
DOWNLOAD EBOOKAuthor: James C. Greenwood
Publisher:
Published: 2005-10-01
Total Pages: 90
ISBN-13: 9781422301586
DOWNLOAD EBOOKWitnesses: Resi Coplan; Ellitt Hahn, Chmn. & Pres., Andrx Corp.; Michael A. Jackson, Exec. V.P., Florida Pharmacy Assoc.; Bentley Lipscomb, State Dir., AARP; Robert N. McEwan, CEO, Medbank of Maryland, Inc.; Carlos A. Ruiz, Pharmacy Dir., Navarro Discount Pharmacies; Gene Sweed; John D. Taylor, Drug Inspector, Florida Dept. of Health, Bureau of Statewide Pharmaceutical Services; & John M. Taylor, Assoc. Commr. of Regulatory Affairs, Food & Drug Admin. (FDA). Charts & tables.
Author:
Publisher:
Published:
Total Pages:
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Congress. House. Committee on Energy and Commerce
Publisher:
Published:
Total Pages: 1124
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Congress. House. Committee on Energy and Commerce
Publisher:
Published: 2005*
Total Pages:
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Congress. House. Committee on Energy and Commerce
Publisher:
Published: 2007*
Total Pages:
ISBN-13:
DOWNLOAD EBOOKAuthor: Institute of Medicine
Publisher: National Academies Press
Published: 2013-06-20
Total Pages: 377
ISBN-13: 0309269393
DOWNLOAD EBOOKThe adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.